PTC Therapeutics, Inc. Increase (Decrease) in Other Operating Liabilities
PTC Therapeutics, Inc. (PTCT) reported Increase (Decrease) in Other Operating Liabilities of -$4.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-07-30
- PTC Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was -$1.82M.
- PTC Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was -$2.31M.
- PTC Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $9.10M, a 45.05% decline year-over-year.
- PTC Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$9.18M.
- PTC Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2025 was -$17.40M, a 247.05% decline from fiscal 2024.
- PTC Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2024 was $11.83M.
- PTC Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was -$2.31M.
- PTC Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2022 was -$4.56M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$4.13M 10-Q · filed 2026-07-30 | $4.98M derived: sum of 3 quarters · filed 2026-07-30 | -$4.20M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$2.31M 10-Q · filed 2026-05-07 | $6.79M derived: sum of 2 quarters · filed 2026-05-07 | -$2.38M derived: sum of 3 quarters · filed 2026-05-07 | -$19.25M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$76.00K derived: sum of 2 quarters · filed 2026-02-19 | -$16.94M derived: sum of 3 quarters · filed 2026-07-30 | -$17.40M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | -$9.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$26.04M derived: sum of 2 quarters · filed 2026-07-30 | -$26.50M 10-Q · filed 2025-11-04 | -$9.93M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | -$16.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$17.32M 10-Q · filed 2026-07-30 | -$757.00K derived: sum of 3 quarters · filed 2026-07-30 | -$2.60M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$458.00K 10-Q · filed 2026-05-07 | $16.11M derived: sum of 2 quarters · filed 2026-05-07 | $14.26M derived: sum of 3 quarters · filed 2026-05-07 | $5.39M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $16.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $14.72M derived: sum of 2 quarters · filed 2026-02-19 | $5.85M derived: sum of 3 quarters · filed 2026-02-19 | $11.83M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | -$1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$10.72M derived: sum of 2 quarters · filed 2025-11-04 | -$4.73M 10-Q · filed 2025-11-04 | -$5.28M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | -$8.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$2.89M 10-Q · filed 2025-08-07 | -$3.44M derived: sum of 3 quarters · filed 2026-02-19 | -$2.14M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $5.98M 10-Q · filed 2025-05-06 | $5.43M derived: sum of 2 quarters · filed 2026-02-19 | $6.73M derived: sum of 3 quarters · filed 2026-02-19 | $7.67M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | -$551.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $748.00K derived: sum of 2 quarters · filed 2026-02-19 | $1.68M derived: sum of 3 quarters · filed 2026-02-19 | -$2.31M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.23M derived: sum of 2 quarters · filed 2024-11-07 | -$1.76M 10-Q · filed 2024-11-07 | -$5.41M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | $933.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$3.06M 10-Q · filed 2024-08-08 | -$6.71M derived: sum of 3 quarters · filed 2025-02-27 | -$3.45M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | -$3.99M 10-Q · filed 2024-04-25 | -$7.64M derived: sum of 2 quarters · filed 2025-02-27 | -$4.38M derived: sum of 3 quarters · filed 2025-02-27 | -$5.46M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | -$3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$391.00K derived: sum of 2 quarters · filed 2025-02-27 | -$1.47M derived: sum of 3 quarters · filed 2025-02-27 | -$4.56M 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | $3.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $2.18M derived: sum of 2 quarters · filed 2023-10-26 | -$908.00K 10-Q · filed 2023-10-26 | -$3.27M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | -$1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$4.17M 10-Q · filed 2023-08-03 | -$6.53M derived: sum of 3 quarters · filed 2024-02-29 | -$7.79M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | -$3.09M 10-Q · filed 2023-04-27 | -$5.45M derived: sum of 2 quarters · filed 2024-02-29 | -$6.71M derived: sum of 3 quarters · filed 2024-02-29 | -$7.88M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | -$2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$3.62M derived: sum of 2 quarters · filed 2024-02-29 | -$4.79M derived: sum of 3 quarters · filed 2024-02-29 | -$6.70M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$2.42M derived: sum of 2 quarters · filed 2022-10-27 | -$4.34M 10-Q · filed 2022-10-27 | -$4.17M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | -$1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$3.08M 10-Q · filed 2022-08-04 | -$2.92M derived: sum of 3 quarters · filed 2023-02-21 | -$2.88M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | -$1.92M 10-Q · filed 2022-05-03 | -$1.75M derived: sum of 2 quarters · filed 2023-02-21 | -$1.71M derived: sum of 3 quarters · filed 2023-02-21 | -$1.48M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $202.00K derived: sum of 2 quarters · filed 2023-02-21 | $433.00K derived: sum of 3 quarters · filed 2023-02-21 | -$3.93M 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $267.00K derived: sum of 2 quarters · filed 2021-10-28 | -$4.10M 10-Q · filed 2021-10-28 | -$4.30M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-06-30 | $231.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$4.13M 10-Q · filed 2021-07-29 | -$4.34M derived: sum of 3 quarters · filed 2022-02-22 | -$15.30M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-03-31 | -$4.36M 10-Q · filed 2021-05-04 | $1.26M 10-Q · filed 2020-04-30 | -$4.57M derived: sum of 2 quarters · filed 2022-02-22 | -$15.53M derived: sum of 3 quarters · filed 2022-02-22 | -$16.20M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | -$204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$11.17M derived: sum of 2 quarters · filed 2022-02-22 | -$11.84M derived: sum of 3 quarters · filed 2022-02-22 | -$3.77M 10-K · filed 2022-02-22 | $13.67M 10-K · filed 2020-03-02 | |||
| 2019-09-30 | -$10.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$11.63M derived: sum of 2 quarters · filed 2020-10-29 | -$3.57M 10-Q · filed 2020-10-29 | $12.55M 10-Q · filed 2019-10-30 | -$3.25M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | -$670.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $7.39M 10-Q · filed 2020-08-05 | $8.65M 10-Q · filed 2019-08-06 | $7.71M derived: sum of 3 quarters · filed 2021-02-25 | $8.84M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | $8.06M 10-Q · filed 2020-04-30 | $8.38M derived: sum of 2 quarters · filed 2021-02-25 | $9.51M derived: sum of 3 quarters · filed 2021-02-25 | $10.47M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.45M derived: sum of 2 quarters · filed 2021-02-25 | $2.41M derived: sum of 3 quarters · filed 2021-02-25 | $1.93M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $2.09M derived: sum of 2 quarters · filed 2019-10-30 | $1.62M 10-Q · filed 2019-10-30 | $1.54M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | $960.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $485.00K 10-Q · filed 2019-08-06 | $411.00K derived: sum of 3 quarters · filed 2020-03-02 | $761.00K derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | -$475.00K 10-Q · filed 2019-05-02 | -$549.00K derived: sum of 2 quarters · filed 2020-03-02 | -$199.00K derived: sum of 3 quarters · filed 2020-03-02 | $882.00K derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | -$74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $276.00K derived: sum of 2 quarters · filed 2020-03-02 | $1.36M derived: sum of 3 quarters · filed 2020-03-02 | $733.00K 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | $350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $1.43M derived: sum of 2 quarters · filed 2018-11-05 | $807.00K 10-Q · filed 2018-11-05 | |||||
| 2017-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $457.00K 10-Q · filed 2018-08-07 | ||||||
| 2017-03-31 | -$624.00K 10-Q · filed 2018-05-09 | |||||||
| 2016-09-30 | $681.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $705.00K derived: sum of 2 quarters · filed 2017-11-02 | $682.00K 10-Q · filed 2017-11-02 | |||||
| 2016-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.00K 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | -$23.00K 10-Q · filed 2017-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |